Belvedere Trading LLC Aclaris Therapeutics, Inc. Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$6.56 - $10.95 $1,128 - $1,883	-172 Reduced 1.11%	15,386 $105,000
Q2 2023 Aug 08, 2023	SELL	$7.89 - $10.64 $131,155 - $176,868	-16,623 Reduced 51.65%	15,558 $161,000
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $227,519 - $577,648	32,181 New	32,181 $260,000
Q2 2021 Jul 23, 2021	SELL	$17.08 - $29.6 $281,358 - $487,600	-16,473 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$5.86 - $27.73 $96,531 - $456,796	16,473 New	16,473 $415,000

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.